AstraZeneca, Merck breast cancer treatment lands FDA approval March 22, 2022 Auto Bot Markets & Regulations 0 The agency has approved Lynparza for use in the US as an adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.
